We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
-13.43%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
10 Year Est. Return
AUM
$3.34B
AUM Growth
+$700M
Cap. Flow
+$1.16B
Cap. Flow %
34.73%
Top 10 Hldgs %
13.4%
Holding
2,173
New
1,007
Increased
282
Reduced
183
Closed
575

Top Sells

Rank Stock Value
1
PBCT
People's United Financial Inc
PBCT
+$63.3M
2
NEM icon
Newmont
NEM
+$40.1M
3
LOW icon
Lowe's Companies
LOW
+$37.7M
4
MMM icon
3M
MMM
+$37.3M
5
FTNT icon
Fortinet
FTNT
+$33.5M

Sector Composition

Rank Sector Weight
1 Technology 15.01%
2 Healthcare 11.5%
3 Industrials 10.54%
4 Energy 9.72%
5 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNUT icon
901
Krispy Kreme
DNUT
$543M
$434K 0.01%
+31,884
New +$440K
EXLS icon
902
EXL Service
EXLS
$4.23B
$434K 0.01%
+14,735
New +$416K
YMAB
903
DELISTED
Y-mAbs Therapeutics
YMAB
$434K 0.01%
28,697
+5,634
+24% +$65.7K
TPGY
904
DELISTED
TPG Pace Beneficial Finance Corp.
TPGY
$432K 0.01%
43,600
VOR icon
905
Vor Biopharma
VOR
$1.04B
$430K 0.01%
4,321
+3,521
+440% +$360K
TFIN icon
906
Triumph Financial Inc
TFIN
$1.84B
$428K 0.01%
+6,841
New +$485K
CELC icon
907
Celcuity
CELC
$4.03B
$427K 0.01%
+46,954
New +$344K
KOPN icon
908
Kopin
KOPN
$663M
$427K 0.01%
381,400
+137,000
+56% +$206K
USNA icon
909
Usana Health Sciences
USNA
$394M
$427K 0.01%
+5,897
New +$439K
TCRR
910
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$427K 0.01%
+147,400
New +$364K
HGEN
911
DELISTED
HUMANIGEN, INC.
HGEN
$425K 0.01%
+239,900
New +$539K
CNK icon
912
Cinemark Holdings
CNK
$3.82B
$424K 0.01%
28,217
-56,426
-67% -$894K
EGO icon
913
Eldorado Gold
EGO
$8.31B
$424K 0.01%
+66,407
New +$604K
KRG icon
914
Kite Realty
KRG
$5.95B
$422K 0.01%
+24,396
New +$504K
MED icon
915
Medifast
MED
$108M
$421K 0.01%
+2,334
New +$418K
BERY
916
DELISTED
Berry Global Group, Inc.
BERY
$420K 0.01%
+8,371
New +$434K
FWONK icon
917
Liberty Media Series C
FWONK
$24.3B
$418K 0.01%
+6,814
New +$417K
QURE icon
918
uniQure
QURE
$2.68B
$418K 0.01%
+22,400
New +$356K
AUS
919
DELISTED
Austerlitz Acquisition Corporation I
AUS
$418K 0.01%
42,916
TFX icon
920
Teleflex
TFX
$5.85B
$417K 0.01%
+1,696
New +$494K
AEHR icon
921
Aehr Test Systems
AEHR
$2.48B
$416K 0.01%
55,490
+43,990
+383% +$365K
CLNN icon
922
Clene
CLNN
$68.9M
$416K 0.01%
+8,259
New +$461K
CTXR icon
923
Citius Pharmaceuticals
CTXR
$14.3M
$416K 0.01%
+18,076
New +$496K
ASXC
924
DELISTED
Asensus Surgical, Inc.
ASXC
$416K 0.01%
1,043,863
+985,763
+1,697% +$440K
BIOT
925
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
$414K 0.01%
+41,773
New +$410K

Similar funds

Ergoteles's Q2 2022 Portfolio in Review

As of Q2 2022, Ergoteles held 2,173 positions worth $3.34B, up 26% from $2.64B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Ergoteles deployed $1.16B of net new capital in Q2 2022, opening 1,007 new positions and adding to 282 existing holdings. Its largest new stake was NXP Semiconductors: 315,378 shares worth $46.7M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 19% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Lowe's Companies, an estimated $37.7M trimmed.

  • Ergoteles's largest Q2 2022 buy was NXP Semiconductors: 315,378 shares worth $46.7M.
  • Ergoteles added most to State Street Technology Select Sector SPDR ETF in Q2 2022, an estimated $58.7M increase.
  • Ergoteles's biggest Q2 2022 reduction was Lowe's Companies, cutting an estimated $37.7M.
  • Ergoteles fully exited People's United Financial Inc in Q2 2022, selling an estimated $63.3M.
  • Ergoteles's ten largest holdings make up 13% of its $3.34B portfolio in Q2 2022.
  • Ergoteles opened 1,007 new positions and closed 575 in Q2 2022.
  • Ergoteles's portfolio value rose 26% quarter-over-quarter to $3.34B.

Based on Ergoteles's 13F filing for Q2 2022, filed 12 Aug 2022.